CRWV is trading at $93.60 (3.1% down) following a multi-day slide fueled by nearly $300 million in insider share sales and concerns over stretched AI infrastructure valuations.
- Investors are showing increased caution due to the company's high liabilities, even as revenue growth remains robust.
- Despite the recent downward pressure, Rosenblatt maintains a strong-buy rating on the stock.